IFF Stock Recent News

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutting-edge dietary supplement plant-based ingredients portfolio of innovative and trusted brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™ in hall 4 at booth 4F25, May 20-22, at the Fira Barcelona Gran Via. "We are excited to highlight.

DUBAI, United Arab Emirates--(BUSINESS WIRE)--IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company's facility in the Dubai Science Park Laboratory Complex. The added facility strengthens IFF's capabilities to serve customers with leading fragrance innovations in one of the fastest-growing regions in the global scent industry. "The Middle East is a key market for IFF's global growth,” said Erik Fyrwald, IFF CEO. “It's expecte.

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version.

IFF plans to consolidate the majority of its business operations in Mexico at a new site within the Tecnoparque business complex to meet customer demand in the region.

International Flavors (IFF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

NEW YORK--(BUSINESS WIRE)--To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at a new site in Mexico City within the Tecnoparque business complex. The move will begin immediately with its Global Business Services Center—which supports the company's full business capabilities serving Mexican and Latin American markets—and is expected to finalize by 2026. IFF's new facilities w.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot facility encompasses state-of-the-art capabilities in botanical research leveraging its LMR by IFF natural ingredients expertise, processing, analytics, product creation for scent and taste, and includes a 360-degree digital immersion room. Designed with sustainability in mind, the center offers j.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages. This innovative product line addresses the industry's concern with nitrosamine risk and mitigation strategies for their formation. Through enhanced process controls and industry-.

PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to manage scent intensity and control malodors. The program combines decades of measured data enhanced by proprietary AI capabilities, along with advanced sensory, technical, consumer and market expertise in various end-user applications. "Science of Performance is a unique approach to scent performance.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production wi.